Seeking Alpha

Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test

FDA approves leading solution for latent tuberculosis diagnostics, advancing global effort to fight infectious diseases “The integration of the Auto-Pure 2400 platform with the T-SPOT.TB test gives ...
Hosted on MSN

FDA approves Revvity’s Auto-Pure platform and tuberculosis test combo

The US Food and Drug Administration (FDA) has granted approval for Revvity’s Auto-Pure 2400 liquid handling platform, used in conjunction with the T-SPOT.TB test. This approval introduces an ...
Medscape

Contribution of Interferon Gamma Release Assays Testing to the Diagnosis of Latent Tuberculosis Infection in HIV-infected Patients

Background: Diagnosis and treatment of latent tuberculosis infection (LTBI) is the most effective strategy to control tuberculosis (TB) among patients with HIV infection. The tuberculin skin test (TST ...
Nasdaq

Revvity Gets FDA Approval For Automated Latent Tuberculosis Test

(RTTNews) - Revvity, Inc. (RVTY), Wednesday said that the U.S. Food and Drug Administration (FDA) has approved the Auto-Pure 2400 liquid handling platform with the T-SPOT. tuberculosis (TB) test. "The ...